Biosolution Co.Ltd (086820) — Capital Reinvestment Ratio
Latest as of September 2025:
1.27x
Biosolution Co.Ltd (086820) has a Capital Reinvestment Ratio of 1.27x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩17.41 Million) in capital expenditures (₩22.15 Million). See Biosolution Co.Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.27x
Capex / Operating Cash Flow
Operating Cash Flow
₩17.41 Million
KRW
Capital Expenditures
₩22.15 Million
KRW
Data as of
Sep 2025
Most recent filing
Biosolution Co.Ltd Capital Reinvestment Ratio (2018–2023)
This chart tracks Biosolution Co.Ltd's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Biosolution Co.Ltd (2018–2023)
Year-by-year Capital Reinvestment Ratio for Biosolution Co.Ltd from 2018 to 2023. For live market cap and broader valuation context, see 086820 market cap overview.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.54x | ₩2.16 Billion | ₩1.16 Billion | ▼ -93.3% |
| 2021 | 7.96x | ₩83.29 Million | ₩663.15 Million | ▲ +1054.8% |
| 2018 | 0.69x | ₩1.03 Billion | ₩707.50 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow